Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) 2021 net profit decreased by 19.54% year on year

On February 25, Guizhou Bailing Group Pharmaceutical Co.Ltd(002424) disclosed the annual performance express of 2021. The company achieved a total operating revenue of 3.093 billion yuan, an increase of 0.17% over the same period of last year; The net profit attributable to shareholders of listed companies was 123 million yuan, a decrease of 19.54% over the same period last year.